Teva Pharma Industries Ltd ADR
Price & Volume
Stats
See moreOpen | $33.61 |
Previous Close | $33.77 |
Day Range | $33.04-$33.88 |
52W Range | $12.47-$37.35 |
Market Cap | $39.1B |
Shares Short | 36M |
Financials
See moreRevenue (12 Mos) | $17.2B |
Revenue Growth (YoY) | 11.4% |
Gross Profit (12 Mos) | $8.9B |
Diluted EPS | $1.21 |
News
See moreYahoo Finance • 7 days ago
U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
Yahoo Finance • 10 days ago
$198.39 Bn Active Pharmaceutical Ingredients (API) Markets, 2030 by Synthesis (synthetic, Biotech), Potency (HPAPI), Product (mAbs, Hormones), Drug (OTC, Rx), Application (Diabetes, Oncology)
Yahoo Finance • 10 days ago
Stanley Druckenmiller's Strategic Moves: A Closer Look at State Street Financial Select Sector ...
Yahoo Finance • 10 days ago
Teva, Sanofi report durable phase 2b efficacy for duvakitug in ulcerative colitis, Crohn’s disease
About
CEO | Mr. Richard D. Francis |
CFO | Mr. Eliyahu Sharon Kalif |
Address | 124 Dvora HaNevi?a St., Tel Aviv-Yafo, Israel, 6944020 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 31,173 |
